Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 74 (ZNF74) is a member of the C2H2-type zinc finger protein family, specifically classified within the KRAB-ZNF (Krüppel-associated box) subfamily[2]. ZNF74 functions as a transcription factor, binding DNA to regulate the expression of specific genes, often through chromatin remodeling and interactions with other components of the transcription machinery[2]. The ZNF74 gene encodes a protein possessing multiple C2H2-type zinc finger repeats and a KRAB domain, both characteristic of DNA-binding transcriptional regulators that also recruit cofactors for gene repression or activation; it plays significant roles in brain development, neural differentiation, and possibly in neurodevelopmental diseases when disrupted, as seen in certain chromosomal abnormalities[2]. There is currently no evidence to support its status as a direct therapeutic target, nor are there known drugs or biomarkers associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 74 (ZNF74).